nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Big data analysis of global advances in pharmaceutics and drug delivery 1980–2014
|
Zhang, Weixiang |
|
2017 |
22 |
8 |
p. 1201-1208 8 p. |
artikel |
2 |
Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs?
|
Dalpiaz, Alessandro |
|
2017 |
22 |
8 |
p. 1134-1138 5 p. |
artikel |
3 |
Contents page 2
|
|
|
2017 |
22 |
8 |
p. ii- 1 p. |
artikel |
4 |
Contents page 1
|
|
|
2017 |
22 |
8 |
p. i- 1 p. |
artikel |
5 |
Gastric bypass surgery mimetic approaches
|
Boettcher, Brian R. |
|
2017 |
22 |
8 |
p. 1242-1249 8 p. |
artikel |
6 |
G-Quadruplex surveillance in BCL-2 gene: a promising therapeutic intervention in cancer treatment
|
Sengupta, Pallabi |
|
2017 |
22 |
8 |
p. 1165-1186 22 p. |
artikel |
7 |
Host-directed therapies offer novel opportunities for the fight against tuberculosis
|
Machelart, Arnaud |
|
2017 |
22 |
8 |
p. 1250-1257 8 p. |
artikel |
8 |
Implementing QM in docking calculations: is it a waste of computational time?
|
Adeniyi, Adebayo A. |
|
2017 |
22 |
8 |
p. 1216-1223 8 p. |
artikel |
9 |
In vitro bioassays to evaluate beneficial and adverse health effects of botanicals: promises and pitfalls
|
Prinsloo, Gerhard |
|
2017 |
22 |
8 |
p. 1187-1200 14 p. |
artikel |
10 |
Lipid based nanocarriers system for topical delivery of photosensitizers
|
Md, Shadab |
|
2017 |
22 |
8 |
p. 1274-1283 10 p. |
artikel |
11 |
Lipid–polymer hybrid nanoparticle-mediated therapeutics delivery: advances and challenges
|
Bose, Rajendran J.C. |
|
2017 |
22 |
8 |
p. 1258-1265 8 p. |
artikel |
12 |
Magnetic nanoformulations for prostate cancer
|
Chowdhury, Pallabita |
|
2017 |
22 |
8 |
p. 1233-1241 9 p. |
artikel |
13 |
Mechanism-based biomarker discovery
|
Antoranz, Asier |
|
2017 |
22 |
8 |
p. 1209-1215 7 p. |
artikel |
14 |
Pan-assay interference compounds (PAINS) that may not be too painful for chemical biology projects
|
Lagorce, David |
|
2017 |
22 |
8 |
p. 1131-1133 3 p. |
artikel |
15 |
Spatiotemporal diversification of intrapatient genomic clones and early drug development concepts realize the roadmap of precision cancer medicine
|
Roukos, Dimitrios H. |
|
2017 |
22 |
8 |
p. 1148-1164 17 p. |
artikel |
16 |
Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives
|
Banerjee, Antara |
|
2017 |
22 |
8 |
p. 1224-1232 9 p. |
artikel |
17 |
Targeting Rabs as a novel therapeutic strategy for cancer therapy
|
Qin, Xiaoyu |
|
2017 |
22 |
8 |
p. 1139-1147 9 p. |
artikel |
18 |
Understanding the checkpoint blockade in lung cancer immunotherapy
|
Dal Bello, Maria Giovanna |
|
2017 |
22 |
8 |
p. 1266-1273 8 p. |
artikel |